NCT00269126View on ClinicalTrials.gov

Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone propionate/salmeterol combination DISKUS

DRUG

salmeterol xinafoate

Trial Locations (2)

602-8026

GSK Investigational Site, Kyoto

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY